Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients

Journal of the Formosan Medical Association

Volumn 104, Issue 5, 2005, Pages 318-326

  Sheng, Wang Huei ^a   Chie, Wei Chu ^b   Chen, Yee Chun ^a   Hung, Chien Ching ^a   Wang, Jann Tay ^a   Chang, Shan Chwen ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b Institute of Preventive Medicine   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cost of illness; Cross infection; Health care costs; Length of stay; Mortality

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE SEVERITY; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL COST; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION CONTROL; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTIPLE ORGAN FAILURE; MYCOSIS; OUTCOME ASSESSMENT; PHARMACY; SHOCK; CASE CONTROL STUDY; CROSS INFECTION; ECONOMICS; LENGTH OF STAY; MIDDLE AGED; STATISTICS; TAIWAN;

AGED; CASE-CONTROL STUDIES; CROSS INFECTION; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; TAIWAN;

EID: 24944459906     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. McGowan JE Jr. Cost and benefit-a critical issue for hospital infection control. Fifth Annual National Foundation for Infectious Diseases Lecture. Am J Infect Control 1982;10:100-8.
2. Haley RW: Measuring the costs of nosocomial infections: methods for estimating economic burden on the hospital. Am J Med 1991;91(3B):32S-8S.
3. Freeman J, McGowan JE Jr: Methodologic issues in hospital epidemiology. III. Investigating the modifying effects of time and severity of underlying illness on estimates of cost of nosocomial infection. Rev Infect Dis 1984;6:285-300.
4. Jarvis WR: Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost and prevention. Infect Control Hosp Epidemiol 1996;17:552-7.
5. Wenzel RP: The economics of nosocomial infections. J Hosp Infect 1995;31:79-87.
6. Haley RW, Schaberg DR, Crossley KB, et al: Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med 1981;70: 51-8.
7. Leroyer A, Bedu A, Lombrail P, et al: Prolongation of hospital stay and extra cost due to hospital-acquired infection in a neonatal unit. J Hosp Infect 1997;35:37-45.
8. Girou E, Stephan F, Novara A, et al: Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Care Med 1998;157:1151-8.
9. Vegas AA, Jodra VM, Garcia ML: Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993;9: 504-10.
10. Wakefield DS, Helms CM, Massanari RM, et al: Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control 1988;16:185-92.
11. Chang SC, Tsai CL, Wang JT, et al: Nosocomial infections in medical centers and regional hospitals between 1999 and 2002 in Taiwan. Infect Control J 2004;14:1-11.
12. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections, 1988. Am J Infection Control 1988;16:128-40.
13. Kreger BE, Craven DE, McCabe WR: Gram-negative bacteremia. Am J Med 1980;68:344-55.
14. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. NCCLS documents, Wayne, Pennsylvania, 2001.
15. Department of Health, Taiwan, ROC. Agency for Healthcare Research and Quality. Available at: URL: http://www.doh.gov.tw/statistic/data
16. Kirkland KB, Briggs JP, Trivette SL, et al: The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725-30.
17. Orsi GB, Stefano LD, Noah N: Hospital-acquired, laboratory-confirmed bloodstream infection-increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002;23:190-7.
18. Haley RW, Schaberg DR, Von Allmen SD, et al: Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis 1980;141:248-57.
19. Dietrich ES, Demmler M, Schulgen G, et al: Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002;30:61-7.
20. Kim T, Oh PI, Simor AE: The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99-104.
21. Digiovine B, Chenoweth C, Watts C, et al: The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Critic Care Med 1999; 160:976-81.
22. Coello R, Glenister H, Fereres J, et al: The cost of infection in surgical patients- a case-control study. J Hosp Infect 1993;25: 239-50.
23. Carmeli Y, Troillet N, Karchmer AW, et al: Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 1999;159:1127-32.
24. Kremery V Jr, Spanik S, Krupova I, et al: Bacteremia due to multi-resistant gram-negative bacilli in neutropenic cancer patients- a case controlled study. J Chemother 1998;10:320-5.
25. Abramson MA, Sexton DJ: Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia- at what costs? Infect Control Hosp Epidemiol 1999; 20:408-11.
26. Harbarth S, Rohner P, Auckenthaler R, et al: Impact and pattern of gram-negative bacteremia during 6 years at a large university hospital. Scand J Infect Dis 1999;31:163-8.
27. Blot S, Vandewoude K, De Bacquer D, et al: Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 2002;34:1600-6.
28. Freeman J, Rosner BA, McGowan JE Jr: Adverse effects of nosocomial infection. J Infect Dis 1979;140:732-40.
29. Whitehouse JD, Friedman ND, Kirkland KB, et al: The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol 2002;23:183-9.
30. Pittet D, Tarara D, Wenzel RP: Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994;271:1598-601.
31. Liu JW, Su YK, Liu CF, et al: Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect 2002; 50:224-7.